- 🏥 The 2021 Exelegent and ApexRCM launch verifies a two-week Healthcare RPA proof-of-concept offer on Microsoft AppSource, but the exact historical listing was not independently confirmed as live in 2026.
- 🤖 Exelegent still actively markets healthcare RPA and revenue cycle automation for eligibility, claims, billing, payment posting, denial follow-up, patient intake, data entry, reporting, and audit support.
- 💳 Microsoft list pricing checked on August 19, 2026 is $15 per Premium user, $150 per Process bot, and $215 per Hosted Process bot per month when paid yearly.
- 🔐 Microsoft includes the Power Automate cloud service in its HIPAA Business Associate Agreement scope, but customer configuration, endpoint controls, PHI handling, and workflow governance remain shared-responsibility issues.
- 🔄 CMS prior authorization APIs arrive primarily on January 1, 2027, so U.S. providers should design portal RPA as a replaceable bridge, not a permanent integration architecture.
The exelegent appsource healthcare rpa microsoft power automate listing began as a 2021 consulting offer for healthcare revenue cycle automation, but the sharper 2026 finding is that the original AppSource page is no longer easy to verify as a live catalog offer while Exelegent still actively markets healthcare RPA, revenue cycle automation, and Microsoft-based services on its own site. That distinction matters for U.S. providers: this should be evaluated as a current consulting and implementation conversation, not assumed to be a self-service Marketplace SKU with unchanged scope or pricing.
The original launch paired Exelegent’s Microsoft Power Automate experience with ApexRCM’s revenue cycle expertise. The 2021 announcement described a two-week proof of concept and positioned RPA around repetitive administrative work. In our review, that historical story still aligns with Exelegent’s current healthcare pages, which emphasize billing, claims, eligibility, payment posting, denial follow-up, reporting, and cross-system execution. Readers who need a broader automation framework can also see our internal guide on how to automate work with AI, which explains why workflow design should come before tool selection.
The market context has also changed. CAQH reported in February 2026 that U.S. healthcare had increased administrative cost avoidance through automated transactions by 17 percent and still had a $21 billion savings opportunity from fully automating manual and partially manual transactions. At the same time, CMS is pushing prior authorization toward standardized APIs, with major API requirements arriving primarily on January 1, 2027. The result is a practical tension: RPA is useful today, but the strongest 2026 deployment should automate work without locking a provider into brittle screen scraping that a payer API may replace next year. (CAQH, 2026; CMS, 2026)
What the 2021 AppSource Offer Actually Was
Exelegent and ApexRCM announced their “RPA for Healthcare” solution on February 10, 2021. The release said the companies would combine Power Automate with revenue cycle management expertise and directed readers to a Microsoft AppSource consulting-services URL for a two-week proof of concept. Exelegent described itself at the time as a six-time Gold Microsoft Partner, which was the partner terminology then in use. (Exelegent, 2021)
The historical positioning was straightforward: use robotic process automation to reduce repetitive back-office work while improving consistency and throughput. Julia Kopko, then Director of Healthcare BPO Services at ApexRCM, said the technology could help teams “focus on patient care and strategic objectives” by reducing monotonous administrative work. The same release claimed adopters could reduce back-office costs by up to 30 percent within 12 months, but that was a vendor launch claim, not an independently audited benchmark, so buyers should not treat it as a guaranteed ROI figure. (Exelegent, 2021)
The listing itself should therefore be read as evidence that an AppSource consulting offer existed, not as proof that every 2021 commercial term remains available in 2026. The exact historical AppSource URL did not resolve cleanly in our current verification, and a current Microsoft Marketplace search for Exelegent healthcare consulting did not surface that specific RPA offer. Exelegent does, however, continue to publish Microsoft Marketplace offers in other service areas and continues to market healthcare RPA through its own site.
What U.S. Buyers Can Verify in 2026
Exelegent’s current healthcare material still supports the core use case. Its ApexRCM page describes healthcare RPA, automated billing and claims, EMR and health data management, and compliance-driven operations. Its 2026 healthcare RPA guidance identifies revenue cycle management, claims processing, billing validation, patient intake, data entry, and compliance reporting as strong candidates for automation. (Exelegent, 2025; Exelegent, 2026)
The current partner language has also changed. Exelegent now describes itself as a Microsoft Partner and, on other current pages, as a Microsoft Solutions Partner. That is more useful for a 2026 buyer than repeating the old Gold designation without context. It indicates an ongoing Microsoft relationship, while the specific scope, staffing model, implementation method, service-level agreement, and healthcare compliance responsibilities still need to be confirmed in the statement of work. (Exelegent, 2026)
For a U.S. deployment, the safest interpretation of the exelegent appsource healthcare rpa microsoft power automate listing is therefore: a historically verified AppSource consulting offer that points to a still-active healthcare automation capability, with current commercial terms requiring direct confirmation. We found no current public Exelegent page that publishes a fixed price for this healthcare RPA engagement.
Verified Status Snapshot
| Question | Verified 2026 finding | Evidence level | Buyer implication |
| Did an AppSource offer exist? | Yes. A 2021 release links to a two-week Healthcare RPA POC on AppSource. | Historical primary vendor release | Treat it as proof of the original offer, not current pricing. |
| Is the exact old listing live now? | Not independently confirmed in our current check. | Current search and direct URL verification | Ask Exelegent for the current Marketplace link. |
| Does Exelegent still offer healthcare RPA? | Yes. Current pages describe healthcare RPA and revenue cycle automation. | Current vendor website | The capability appears active outside the old listing. |
| Is fixed consulting pricing public? | No verified public fixed price found for this engagement. | Current public pages reviewed | Request a scope-based proposal and separate license costs. |
Where Power Automate Fits in a Healthcare RPA Stack
Power Automate can support both API-driven cloud flows and desktop RPA. The architecture choice matters more than the brand name because each execution mode has different reliability, licensing, and compliance implications. A cloud flow is the better fit when a payer, EHR, billing platform, or Microsoft service exposes a stable connector or API. Desktop RPA is the bridge when staff still have to click through legacy Windows applications or payer portals that do not expose usable APIs.
Microsoft’s current licensing documentation makes that split explicit. Power Automate Premium gives a licensed user cloud automation plus attended desktop RPA. Power Automate Process adds capacity for unattended desktop execution, and Hosted Process adds a Microsoft-hosted virtual machine. Teams designing a broader Microsoft automation stack should also review our guide to automating a workflow with Microsoft Copilot, where we separate AI interpretation from deterministic Power Automate controls. (Microsoft, 2026)
That separation is especially useful in healthcare. A language model can classify a denial letter or extract fields from a document, but the transaction logic that updates a work queue, checks required fields, applies a payer rule, records an audit event, and routes an exception should remain explicit. The goal is controlled orchestration, not maximum autonomy.
Power Automate Deployment Options Compared
| Mode | Best fit | 2026 list price | Healthcare strength | Main caution |
| Premium user | Cloud flows and attended desktop RPA | $15/user/month | Good for maker-led or staff-assisted workflows | User licensing and attended execution are not unattended bot capacity. |
| Process bot | Unattended desktop RPA or independently licensed process | $150/bot/month | Good for scheduled or queue-driven back-office work | Requires machine capacity planning, monitoring, and exception ownership. |
| Hosted Process | Unattended RPA with Microsoft-hosted VM | $215/bot/month | Reduces customer VM administration | Higher list cost and still requires workflow governance. |
| API-first cloud flow | Systems with supported APIs or connectors | Depends on license and connector mix | Less brittle than screen automation | API coverage and payer/EHR capabilities vary. |
The Revenue Cycle Jobs That Make Sense to Automate
The best revenue cycle candidates share four traits: high volume, rules that can be written down, stable inputs, and an exception path that humans can own. Exelegent’s current revenue cycle material specifically names eligibility verification, claims validation and submission, denial follow-up, payment posting, reconciliation, reporting, and audit support. Those areas also match the administrative categories tracked by CAQH. (Exelegent, 2026; CAQH, 2026)
Prior authorization deserves separate treatment. It is attractive for automation because it involves repetitive status checks, documentation gathering, and payer-specific steps, yet it can directly affect patient access to care. CMS now requires impacted payers to report prior authorization metrics and, beginning primarily in 2027, implement APIs that support request and response exchange. That means a 2026 RPA design should automate clerical preparation and status handling while preserving clinical review and making it easy to replace portal steps with API calls when payer support matures. (CMS, 2026)
This is also where agentic AI should be bounded. Our internal AI agent for healthcare guide argues for permission, provenance, confidence, and consequence gates. For revenue cycle teams, that translates into a simple operating rule: software may gather, validate, route, and draft, but denials, medical-necessity disputes, unusual eligibility conflicts, and patient-facing commitments need named human ownership.
Revenue Cycle Automation Fit
| Workflow | Automation fit | Human control point | Useful metric |
| Eligibility verification | High when payer inputs are stable | Coverage conflicts and unusual benefit rules | Seconds per check, exception rate |
| Claims validation and submission | High for deterministic edits and completeness checks | Coding disputes and unusual payer rules | First-pass success, rework rate |
| Denial follow-up | Medium to high for routing and status work | Appeals strategy and medical necessity | Days to action, recovery rate |
| Payment posting and reconciliation | High for structured remittance workflows | Unmatched or ambiguous payments | Auto-post rate, reconciliation backlog |
| Prior authorization | Medium, rising as APIs mature | Clinical review and consequential exceptions | Turnaround time, manual touches |
| Reporting and audit evidence | High for scheduled extraction and logs | Metric interpretation and compliance review | Report cycle time, missing evidence |
Pricing and Deployment Choices for U.S. Providers
Microsoft’s published U.S. list prices provide a useful platform baseline, but they are not the price of an Exelegent implementation. Power Automate Premium is currently $15 per user per month when paid yearly. Power Automate Process is $150 per bot per month, and Hosted Process is $215 per bot per month. On a simple annual basis, that is $180 per Premium user, $1,800 per Process bot, and $2,580 per Hosted Process bot before tax, consulting, support, or other Microsoft capacity. (Microsoft, 2026)
The $780 annual difference between Process and Hosted Process per bot is effectively the list-price premium for Microsoft’s hosted machine layer. That can be attractive when a provider wants to avoid maintaining its own RPA virtual machines, but machine hosting is only one part of total cost. Implementation design, premium connectors, testing environments, exception handling, monitoring, identity administration, change management, and support can outweigh the license delta.
The 2021 launch release quoted a much older average of roughly $40 per user and offered a temporary proof-of-concept discount. Neither figure should be used for 2026 budgeting. For the exelegent appsource healthcare rpa microsoft power automate listing, the only defensible pricing approach today is to separate Microsoft licensing from Exelegent professional services and request a current scope-based proposal.
HIPAA, Security, and the Control Gap
Microsoft explicitly lists the Power Automate cloud service among services covered by its HIPAA Business Associate Agreement for eligible covered entities and business associates. Microsoft also states that a BAA does not make a customer’s environment compliant by itself. The healthcare organization remains responsible for its own program, configuration, policies, and use of the service. (Microsoft, 2025)
That shared-responsibility point becomes more important with desktop RPA. A bot may cross a cloud flow, a Windows session, a browser, a payer portal, an EHR, a local file system, and a credential store in one run. Each hop creates a control decision. Providers should validate service accounts, least-privilege access, MFA exceptions, credential vaulting, session isolation, PHI persistence, log contents, screenshots, downloads, retention, and incident-response ownership before production.
Power Platform data policies can classify connectors and block risky combinations, while audit capabilities record important Power Automate events. Those controls do not remove the need for workflow-level governance. A flow can be technically permitted and still be operationally unsafe if it sends PHI to the wrong destination or silently retries a failed patient update. Our internal AI agent vs automation analysis makes the same point from another angle: predictable work benefits from fixed rules, while adaptive systems need tighter guardrails because flexibility expands the failure surface. (Microsoft, 2026)
The Hidden Risk: Portal Bots in an API-First 2027 World
The hidden strategic risk in healthcare RPA is not that robots stop working. It is that they keep working against an interface that should no longer be the integration layer. Screen-based automation is often the fastest way to bridge a payer portal or legacy application, but it is sensitive to UI changes, browser updates, authentication redesigns, pop-ups, session timeouts, and altered field labels.
CMS is now changing the economics of that trade-off. Its 2024 Interoperability and Prior Authorization Final Rule requires impacted payers to implement key APIs primarily by January 1, 2027. The Prior Authorization API is intended to let providers determine requirements, submit requests, receive approvals or denials with reasons, and exchange information electronically. This does not eliminate every portal workflow, but it reduces the long-term case for building large, irreversible investments around web-page clicking where a standards-based API is becoming available. (CMS, 2026)
A strong 2026 design therefore uses RPA as a replaceable adapter. Business rules, queues, audit events, metrics, and exception logic should sit outside the brittle UI layer. If a payer introduces a FHIR-based API, the organization should be able to swap the connector without redesigning the whole revenue cycle process. That is a more durable interpretation of low-code automation than simply recording mouse clicks.
The Future of Healthcare RPA and Power Automate in 2027
By 2027, healthcare automation will likely become more hybrid. Deterministic Power Automate flows will continue to handle triggers, approvals, routing, and system updates. Desktop RPA will remain necessary for legacy applications and lagging payer portals. API adoption should expand for prior authorization and other interoperability workflows, while AI components increasingly handle document classification, summarization, extraction, and exception triage.
The strongest signal is not that AI will replace RPA. It is that the boundary between rules and reasoning is becoming clearer. CAQH’s 2025 Index found that more than half of health plans and one quarter of provider organizations were already using AI tools in administrative workflows, yet it also identified a $21 billion remaining savings opportunity from fuller automation. That combination suggests the next gains will come from redesigning end-to-end work rather than adding isolated bots. (CAQH, 2026)
For readers tracking broader adoption, our AI tool adoption by industry report reaches the same conclusion: healthcare value depends on validation, privacy, reliability, and operating redesign. The future of the exelegent appsource healthcare rpa microsoft power automate listing is therefore less about whether one old Marketplace page returns. The more important question is whether Exelegent can map its current healthcare services onto a provider’s 2027 architecture, including API migration, governed RPA, Power Platform controls, and measurable operational ownership.
Takeaways
- Treat the 2021 AppSource offer as historically verified, not automatically current. Exelegent still markets healthcare RPA, but the exact old Marketplace listing was not independently confirmed as live in 2026.
- Separate Microsoft licensing from consulting cost. Current list prices are $15 per Premium user, $150 per Process bot, and $215 per Hosted Process bot per month when paid yearly.
- Prioritize high-volume, rule-based revenue cycle work such as eligibility, claims validation, payment posting, denial follow-up, and reporting.
- Use API-based cloud flows where stable APIs exist, and use desktop RPA as a replaceable bridge for legacy portals and applications.
- HIPAA support is not a compliance shortcut. Microsoft includes the Power Automate cloud service in its BAA scope, while customers remain responsible for configuration, process controls, and data handling.
- Design prior authorization automation for the January 2027 API shift, keeping clinical judgment and complex exceptions with people.
- Measure cycle time, exception rate, first-pass success, rework, and maintenance cost before scaling any bot estate.
Conclusion
The exelegent appsource healthcare rpa microsoft power automate listing is best understood as a useful historical marker for a healthcare automation service that has continued to evolve outside the original 2021 AppSource page. Exelegent still presents healthcare RPA and revenue cycle automation as active capabilities, while Microsoft’s platform now offers clearer licensing, stronger governance tools, and a more mature split between cloud flows and desktop RPA. For U.S. providers, the decision is not whether automation is valuable. CAQH’s latest figures show that administrative automation is already producing large system-wide savings. The decision is how to build it without creating a brittle second layer of technical debt. A sensible deployment starts with measurable, rules-based work, preserves human review for consequential exceptions, treats HIPAA as shared responsibility, and keeps portal bots replaceable as CMS-driven APIs arrive in 2027. That makes RPA a bridge to a cleaner operating model rather than a permanent dependency on old screens.
FAQ
Is the Exelegent Healthcare RPA AppSource listing still live in 2026?
We verified the 2021 announcement and its AppSource URL, but the exact historical listing did not resolve cleanly in our current check and did not surface in current Marketplace search results. Exelegent still actively markets healthcare RPA and revenue cycle automation on its own website. Buyers should request a current Marketplace link or proposal directly from Exelegent rather than assume the 2021 listing terms remain active.
What was the exelegent appsource healthcare rpa microsoft power automate listing designed to automate?
The original offer centered on healthcare back-office and revenue cycle work using Microsoft Power Automate. Current Exelegent materials identify eligibility verification, claims processing and validation, billing, payment posting, denial follow-up, patient intake, data entry, reporting, and compliance support as suitable RPA or workflow-automation candidates.
How much does Microsoft Power Automate cost for healthcare RPA?
Microsoft currently lists Power Automate Premium at $15 per user per month, Process at $150 per bot per month, and Hosted Process at $215 per bot per month when paid yearly. These are platform prices, not Exelegent consulting prices. Implementation, premium connectors, environments, support, monitoring, and healthcare-specific controls can add cost.
Can Power Automate be used in a HIPAA-regulated healthcare environment?
Yes. Microsoft lists the Power Automate cloud service among services covered by its HIPAA Business Associate Agreement for eligible customers. Microsoft also states that using covered services does not itself make an organization HIPAA compliant. Providers still need appropriate policies, access controls, data handling, risk management, and workflow governance.
Should a U.S. provider automate prior authorization with RPA in 2026?
Yes, but with an exit path. RPA can help with document gathering, portal status checks, routing, and repetitive submission steps. CMS requires key prior authorization APIs primarily by January 1, 2027, so providers should keep UI automation modular and be prepared to replace portal steps with standards-based API integrations as payer support becomes available.
Is desktop RPA better than cloud flows for healthcare revenue cycle work?
Neither is universally better. Cloud flows are preferable when a stable API or connector exists because they are generally less fragile than screen automation. Desktop RPA is useful when staff must interact with legacy applications or payer portals. Many production healthcare workflows need both, with centralized logging, exception queues, and human review.
What should a healthcare organization ask Exelegent before deployment?
Ask for the current service scope, Microsoft Marketplace status, fixed or variable professional-services pricing, target systems, supported automation modes, security architecture, PHI handling, credential model, monitoring, support SLAs, change-management process, measurable success metrics, and a migration plan from portal RPA to APIs where relevant.
References
Centers for Medicare & Medicaid Services. (2026, July 27). Prior Authorization API.
Exelegent. (2026). RPA in healthcare: 7 automation wins for CFOs and COOs.
Exelegent. (2026). Healthcare revenue cycle automation: 6 ways to improve.
Exelegent. (2025). ApexRCM Healthcare.
Exelegent. (2026). Microsoft Partner.
Microsoft. (2026). Power Automate pricing.
Microsoft. (2026, July 20). Types of Power Automate licenses.
Microsoft. (2026, May 29). Compliance and data privacy in Power Platform.
Microsoft. (2026, April 8). Data policies in Power Platform.
Microsoft. (2025, July 29). HIPAA and HITECH Act compliance offering.
Methodology
We reviewed the user’s supplied keyword brief, Exelegent’s current healthcare and Microsoft Partner pages, the 2021 Exelegent/ApexRCM launch announcement, current Microsoft Power Automate pricing and licensing documentation, Microsoft’s HIPAA/HITECH compliance documentation, Power Platform governance guidance, CAQH’s 2025 Index summary, and current CMS prior authorization requirements. We separately verified five live Perplexity AI Magazine pages before using them as internal links. We did not treat Exelegent’s 2021 cost-savings claim as an independently validated outcome, and we could not independently confirm the exact historical Healthcare RPA AppSource listing as a currently live offer. Pricing is current Microsoft list pricing as checked on August 19, 2026 and may change. This article is informational and does not constitute legal, compliance, or procurement advice.
This article was drafted with AI assistance and reviewed by the Perplexity AI Editorial Team. All data, citations, and claims have been independently verified against primary sources.
